MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9) — Houston, Texas

MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9) is a clinical research site located in Houston, Texas, United States 77030-4009.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9) has participated in 1 clinical trials.

Therapeutic areas: Symptomatic Refractory Resistant Carcinoid Disease.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9)?

MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9) conducted?

MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9) has 1 clinical trials on record. Their work covers Symptomatic Refractory Resistant Carcinoid Disease.

Is MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9) accredited by Crixeo Health?

MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.